Quick Search

 

 


 

 

Home > Result Summaries: Compounds > ropinirole > Result Summary for 108862

Result Summary for 108862

Result Summary
Protocol ID: 108862
Clinical Study ID: 108862
Official Title: Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients with Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
Phase: phase 4
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Fumihito Yoshii, Hidekatsu Motoyama. Efficacy and safety of long-term and high-dose treatment with ropinirole in Japanese patients with Parkinson's disease (LEAD-PD study). [Ther Res]. 2011;32(8):1033-1046.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.